XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Apr. 01, 2023
Apr. 02, 2022
Operating Activities    
Net Income Attributable to Kadant $ 28,075 $ 41,192
Net income attributable to noncontrolling interest 184 249
Net Income 28,259 41,441
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 8,446 9,445
Stock-based compensation expense 2,238 2,260
Gain on the sale of assets (Note 2) 0 (20,190)
Non-cash impairment costs (Note 2) 0 182
Other items, net 842 6,325
Changes in assets and liabilities, net of effects of acquisitions:    
Accounts receivable 517 (9,127)
Contract assets 2,637 (409)
Inventories (13,997) (9,359)
Other assets 1,293 1,113
Accounts payable 77 8,864
Customer deposits 11,114 3,329
Other liabilities (4,560) (10,106)
Net cash provided by operating activities 36,866 23,768
Investing Activities    
Acquisition, net of cash acquired 0 (62)
Purchases of property, plant, and equipment (4,469) (2,868)
Proceeds from sale of property, plant, and equipment 32 1,595
Other investing activities (30) 44
Net cash used in investing activities (4,467) (1,291)
Financing Activities    
Proceeds from issuance of short- and long-term obligations 0 15,516
Repayment of short- and long-term obligations (20,761) (35,064)
Tax withholding payments related to stock-based compensation (3,897) (4,550)
Dividends paid (3,036) (2,905)
Other financing activities (63) 0
Net cash used in financing activities (27,757) (27,003)
Exchange Rate Effect on Cash, Cash Equivalents, and Restricted Cash 1,140 (664)
Increase (Decrease) in Cash, Cash Equivalents, and Restricted Cash 5,782 (5,190)
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period 79,725 94,161
Cash, Cash Equivalents, and Restricted Cash at End of Period $ 85,507 $ 88,971